State of Tennessee, Department of Treasury

Position in ROIV — Roivant Sciences Ltd.

CIK 1587973 NASHVILLE, TN

Position in ROIV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,580,889

+$1,166,244 QoQ

Shares Held

129,274

+16.2% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

State of Tennessee, Department of Treasury holds $125,190,066 across 33 Biotechnology names. ROIV ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	81,668	$36,468,028
2	REGN	Regeneron Pharmaceuticals, Inc.	41,458	$32,032,109
3	JAZZ	Jazz Pharmaceuticals plc	29,581	$5,592,288
4	BMRN	Biomarin Pharmaceutical Inc	91,261	$5,155,333
5	EXEL	Exelixis, Inc.	119,701	$5,133,975
6	HALO	Halozyme Therapeutics, Inc.	57,516	$3,717,259
7	ROIV	Roivant Sciences Ltd. This page	129,274	$3,580,889
8	INCY	Incyte Corp	37,020	$3,484,322

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,580,889	129,274	+16.2%	Shares	Sole	2026-05-15
2025-12-31	$2,414,645	111,274	-36.6%	Shares	Sole	2026-02-18
2025-09-30	$2,655,103	175,486	+83.5%	Shares	Sole	2025-11-14
2025-06-30	$1,077,862	95,640	-35.3%	Shares	Sole	2025-08-15
2025-03-31	$1,491,655	147,835	+12.7%	Shares	Sole	2025-05-13
2024-12-31	$1,552,368	131,223	-2.7%	Shares	Sole	2025-02-13
2024-09-30	$1,557,046	134,926	-2.5%	Shares	Sole	2024-11-14
2024-06-30	$1,463,035	138,414	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.